EpiPaws Captures Attention at CrocTank with Offer from Kevin O’Leary

6 December 2024

BOCA RATON, FL – December 4, 2025

Big News from EpiPaws! At this year’s CrocTank pitch competition at Florida Atlantic University (FAU), we had the honor of presenting our mission to revolutionize pet health to a panel of powerhouse investors, including Kevin O’Leary, Daymond John, and Robert Herjavec.

After showcasing our groundbreaking Pet Age Test, which uses epigenetics to determine the age of dogs and cats, Kevin O’Leary extended a $250,000 investment offer for EpiPaws. Daymond John added his praise.

“At EpiPaws, we’re committed to driving innovation in pet health, and we’re excited to receive interest from top tier investors like Kevin O’Leary’s, who have previously backed Basepaws. Together, we can make a real difference in how we care proactively for animals.”

– Dr. Andria Beal, Founder and CEO of EpiPaws

We’re now in deeper discussions with O’Leary to explore the best path forward for EpiPaws. This is an exciting opportunity for investors, customers, and partners who share our vision of transforming pet health and wellness.

Stay tuned as we continue to grow, innovate, and redefine what’s possible in pet health. For more information about EpiPaws and our cutting-edge genetic testing solutions, visit www.epipaws.com.

You can also sign up for the EpiPaws Newsletter on our website homepage and purchase our first product, The Pet Age Test.

Thank you for being part of our journey - here’s to a better future for all pets!

More About EpiPaws

EpiPaws is on a mission to make pet healthcare proactive. This means better tools to measure and track health as well as a greater understanding of how disease develops and of how the environment influences pet health. EpiPaws is founded by Epigenetic Scientist Dr. Andria Beal.